Evidence map›Paper›PMID 33373844›Full record

ArticleColloids and surfaces. B, Biointerfaces2021

A comparison of the location in membranes of curcumin and curcumin-derived bivalent compounds with potential neuroprotective capacity for Alzheimer's disease.

Alessio Ausili, Victoria Gómez-Murcia, Adela M Candel, Andrea Beltrán, Alejandro Torrecillas, Liu He, Yuqi Jiang, Shijun Zhang, José A Teruel, Juan C Gómez-Fernández

Open access · greenAbstract read
In one paragraph

Article in Colloids and surfaces. B, Biointerfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Alessio AusiliDepartamento De Bioquímica y Biología Molecular "A", Facultad de Veterinaria, Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia, Apartado de Correos 4021, Murcia, E-30080, Spain.
Victoria Gómez-MurciaDepartamento de Farmacología, Facultad de Medicina, IMIB, Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia, Apartado de Correos 4021, Murcia, E-30080, Spain.
Adela M CandelDepartamento De Bioquímica y Biología Molecular "A", Facultad de Veterinaria, Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia, Apartado de Correos 4021, Murcia, E-30080, Spain.
Andrea BeltránDepartamento De Bioquímica y Biología Molecular "A", Facultad de Veterinaria, Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia, Apartado de Correos 4021, Murcia, E-30080, Spain.
Alejandro TorrecillasDepartamento De Bioquímica y Biología Molecular "A", Facultad de Veterinaria, Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia, Apartado de Correos 4021, Murcia, E-30080, Spain.
Liu HeDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, 23298, United States.
Yuqi JiangDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, 23298, United States.
Shijun ZhangDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, 23298, United States.
José A TeruelDepartamento De Bioquímica y Biología Molecular "A", Facultad de Veterinaria, Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia, Apartado de Correos 4021, Murcia, E-30080, Spain.
Juan C Gómez-FernándezDepartamento De Bioquímica y Biología Molecular "A", Facultad de Veterinaria, Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia, Apartado de Correos 4021, Murcia, E-30080, Spain. Electronic address: jcgomez@um.es.
Universidad de Murcia · ESVirginia Commonwealth University · US

Funding

Development of NLRP3 inflammasome inhibitors towards Alzheimer's diseaseR01AG058673 · NIA · VIRGINIA COMMONWEALTH UNIVERSITY · PI WANG, XIANG-YANG SHAWN, ZHANG, SHIJUN · 2018 to 2020
$2.3M
NIA NIH HHS R01 AG058673
6 · The paper itself

Abstract

Curcumin and two bivalent compounds, namely 17MD and 21MO, both obtained by conjugation of curcumin with a steroid molecule that acts as a membrane anchor, were comparatively studied. When incorporated into 1,2-dipalmitoyl-sn-glycero-3-phosphocholine the compounds showed a very limited solubility in the model membranes. Curcumin and the two bivalent compounds were also incorporated in membranes of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine and quenching the fluorescence of pure curcumin or of the curcumin moiety in the bivalent compounds by acrylamide it was seen that curcumin was accessible to this water soluble quencher but the molecule was somehow located in a hydrophobic environment. This was confirmed by quenching with doxyl-phosphatidylcholines, indicating that the curcumin moieties of 17MD and 21MO were in a more polar environment than pure curcumin itself.

Indexed as

Alzheimer DiseaseCurcuminHumansHydrophobic and Hydrophilic InteractionsLipid BilayersMagnetic Resonance SpectroscopyPhosphatidylcholinesWaterCurcuminLipid BilayersPhosphatidylcholinesWater(1)H NOESY MAS-NMRCurcuminDSCFluorescence quenchingMembranes

Identifiers

PMID33373844
PMCPMC7965246
OpenAlexW3111226396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.